BNET Industries
Charles River Laboratories International Inc. (CRL) is in the Pharma Industry
- Revenue
- Dec 29 2007
- $1.2B
- Profit
- Dec 29 2007
- $154.4M
- Market Cap
- Aug 27 2008
- $4.4B
Latest News and Analysis
Charles River Laboratories International Inc. Q2 2008 Earnings Call Transcript
Charles River Laboratories International Inc. CRL Q2 2008 Earnings Call
Charles River Laboratories International Inc. Q1 2008 Earnings Call Transcript
Charles River Laboratories International Inc. Q1 2008 Earnings Call Transcript
Charles River Laboratories International Q4 2007 Earnings Call Transcript
Charles River Laboratories International Q4 2007 Earnings Call Transcript
Charles River Laboratories 2008 Guidance Call Transcript
Charles River Laboratories 2008 Guidance Call Transcript
Charles River Laboratories Q3 2007 Earnings Call Transcript
Charles River Laboratories Q3 2007 Earnings Call Transcript
Charles River Laboratories Q2 2007 Earnings Call Transcript
Charles River Laboratories Q2 2007 Earnings Call Transcript
Additional Resources
Charles River Announces Second-Quarter 2008 Results
- Second-Quarter Sales Increase 14.5% to $352 Million - - Second-Quarter GAAP EPS Increase 29% to $0.71 and Non-GAAP EPS Increase 23% to $0.79 - - Raising 2008 Sales and Non-GAAP EPS Guidance, GAAP EPS Guidance Lowered - - Agreement Signed to...
Charles River Supports the National Cancer Institute and Establishes New RMS Operations
Leading CRO expands footprint in Maryland to support customer demand and RMS geographic growth WILMINGTON, Mass. -- In response to increasing demand and to better serve its customer the National Cancer Institute NCI, Charles River Laboratories International, Inc. (NYSE: CRL) today announced the opening of its 52,000 square...
Charles River Schedules Second-Quarter 2008 Earnings Release and Conference Call
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2008 financial results on Tuesday, August 5th after the market closes. A conference call has been scheduled to discuss the results on Wednesday, August 6th at 8:30 a.m. ET. Investors will have...
Charles River to Present at Jefferies Healthcare Conference
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2nd Annual Healthcare Conference in New York, New York on Wednesday, June 25th at 9:00 a.m. ET. Management will present an overview of Charles River's strategic focus and...
Charles River to Present at William Blair Growth Stock Conference
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the William Blair 28th Annual Growth Stock Conference in Chicago, Illinois on Wednesday, June 18th at 8:30 a.m. CT (9:30 a.m. ET). Mr....
Charles River to Present at Goldman Sachs Healthcare Conference
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Goldman Sachs 29th Annual Global Healthcare Conference in Dana Point, California on Wednesday, June 11th at 10:00 a.m. PT (1:00 p.m....
Charles River to Webcast Investor Meeting
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it will hold a meeting for the investment community with its management team on Wednesday, June 4, 2008. Investors as well as the general public are invited to listen to a live webcast of the meeting which is...
Charles River to Present at Bank of America and Baird Conferences
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at two upcoming conferences. Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Bank of America 2008 Health Care Conference in Las Vegas, Nevada, on Tuesday, May 13, 2008 at...
Charles River Announces First-Quarter 2008 Results
- First-Quarter Sales Increase 16% to $338 Million Due to Strong Customer Demand - - First-Quarter GAAP EPS of $0.64 and Non-GAAP EPS of $0.72 - - Reaffirms Guidance for 2008 - WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) today reported...
Charles River Schedules First-Quarter 2008 Earnings Release and Conference Call
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2008 financial results on Tuesday, May 6th after the market closes. A conference call has been scheduled to discuss the results on Wednesday, May 7th at 8:30 a.m. ET. Investors will have the opportunity to...
Charles River to Present at Cowen and Lehman Brothers Conferences
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at the two upcoming healthcare conferences. On Tuesday, March 18th at 10:15 a.m. ET, Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Cowen and Company 28th Annual Health Care...
Charles River Laboratories to Present at Raymond James Conference
WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the Raymond James 29th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 4that 1:05 p.m. ET. Mr. Foster will present an overview of Charles...
Has added Charles River Laboratories International Inc. to their watch list.
M2 PRESSWIRE-12 February 2008-MG Strategies: Has added Charles River Laboratories International Inc. to their watch list.C1994-2008 M2 COMMUNICATIONS LTD RDATE:12022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants,...
Charles River Announces Fourth-Quarter and Full-Year 2007 Results from Continuing Operations
- Strong Customer Demand Drives Double-Digit Sales and Earnings Growth - - Fourth-Quarter Sales Increase 17.0% and Full Year Rises 16.3% to $1.23 Billion - - Fourth-Quarter GAAP EPS of $0.55 and Non-GAAP EPS of $0.65 - - 2007 GAAP EPS of $2.29 and...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View Related Content by Tag Close
- Incorporated: 1994
- CEO: Mr. James C. Foster
Charles River Laboratories International is a provider of services that advance the drug discovery and development process. Co. has two reporting segments: Research Models and Services is engaged in production and sale of research models, principally genetically and virally defined purpose-bred rats and mice; Co.'s Preclinical Services provides in vivo and in vitro studies, supportive laboratory services, and strategic preclinical consulting and program management to support new drug development. As of Dec 31 2007, Co. operated approximately 60 facilities, including its production and warehousing facilities, throughout 15 countries worldwide.
Key Competitors
Charles River Laboratories International Inc. Company Info
Board of Directors
Mr. James C. Foster
Chairman
Dr. Nancy T. Chang
Mr. Stephen D. Chubb
Mr. C. Richard Reese
Mr. George E. Massaro
Dr. George M. Milne Jr., Ph.
Mr. Douglas E. Rogers
Dr. Samuel O. Thier M.D.
Mr. William H. Waltrip
Contact Information
251 Ballardvale Street
Wilmington, MA
781 222-6000